financial statements
The full income statement, balance sheet, and cash-flow statement for Healthpeak Properties Inc. (DOC), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 604M YoY+6.2% | 568M YoY+7.8% | 527M YoY+6.6% | 495M YoY+5.0% | 471M YoY+8.0% | |
| Cost of revenue | — | 1.07B YoY+19.2% | 902M YoY+4.5% | 863M YoY+11.6% | 773M YoY-1.2% | |
— | — | 902M YoY+4.5% | 863M YoY+11.6% | 773M YoY-1.2% | ||
| Interest expense | 305M YoY+8.8% | 280M YoY+40.0% | 200M YoY+15.8% | 173M YoY+9.5% | 158M YoY-27.6% | |
| Interest & investment income | 61.8M YoY+38.0% | 44.8M YoY+105.6% | 21.8M YoY-6.5% | 23.3M YoY-38.3% | 37.8M YoY+128.2% | |
| Other non-operating income | 479K YoY-99.2% | 59.3M YoY+771.7% | 6.81M YoY-97.9% | 326M YoY+5107.0% | 6.27M YoY-97.3% | |
| Equity-method income | -174M YoY-11384.1% | -1.51M YoY-114.8% | 10.2M YoY+414.1% | 1.99M YoY-67.5% | 6.10M YoY+109.2% | |
| Pre-tax income | 284M YoY+4.1% | 273M YoY-13.3% | 315M YoY-37.9% | 507M YoY+295.1% | 128M YoY-41.0% | |
| Income tax | 9.28M YoY+113.4% | 4.35M YoY+145.2% | -9.62M YoY-117.3% | -4.42M YoY-35.7% | -3.26M YoY+65.4% | |
71.3M YoY-70.7% | 243M YoY-20.5% | 306M YoY-38.9% | 500M YoY-1.0% | 506M YoY+22.2% | ||
$0.10 YoY-72.2% | $0.36 YoY-35.7% | $0.56 YoY-39.1% | $0.92 YoY-1.1% | $0.93 YoY+20.8% | ||
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Cash & equivalents | 467M YoY+290.1% | 120M YoY+1.9% | 118M YoY+63.3% | 72.0M YoY-54.5% | 158M YoY+257.9% | |
20.3B YoY+2.0% | 19.9B YoY+27.0% | 15.7B YoY-0.5% | 15.8B YoY+3.4% | 15.3B YoY-4.2% | ||
12.0B YoY+10.6% | 10.9B YoY+24.0% | 8.77B YoY+3.4% | 8.48B YoY+4.6% | 8.11B YoY-5.4% | ||
7.50B YoY-10.7% | 8.40B YoY+32.3% | 6.35B YoY-4.6% | 6.65B YoY+2.1% | 6.52B YoY-3.2% | ||
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
1.25B YoY+17.0% | 1.07B YoY+11.9% | 956M YoY+6.2% | 900M YoY+13.2% | 795M YoY+4.9% | ||
-1.03B YoY-809.2% | -114M YoY+80.3% | -577M YoY+34.2% | -876M YoY-265.0% | 531M YoY+152.7% | ||
136M YoY+114.5% | -941M YoY-179.1% | -337M YoY-189.4% | -117M YoY+91.0% | -1.29B YoY-622.8% | ||
| FX effect on cash | — | — | — | 0.00 | 0.00 YoY+100.0% | |
| Net change in cash | 353M YoY+2212.5% | 15.3M YoY-63.8% | 42.2M YoY+145.6% | -92.6M YoY-345.3% | 37.8M YoY+1370.6% | |
| Interest paid | 260M YoY+4.3% | 249M YoY+32.5% | 188M YoY+16.1% | 162M YoY-6.3% | 173M YoY-17.5% | |
| Income taxes paid | 3.41M YoY-56.6% | 7.86M YoY+308.8% | 1.92M YoY+201.1% | -1.90M YoY-142.1% | 4.52M YoY+675.2% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 11.2B YoY-21.2% | 14.2B YoY+30.9% | 10.8B YoY-19.6% | 13.5B YoY-30.7% | 19.5B YoY+19.5% | |
| P/E | 156.6× YoY+168.6% | 58.3× YoY+30.1% | 44.8× YoY+73.2% | 25.9× YoY-32.7% | 38.5× YoY-2.2% | |
| P/S | 18.5× YoY-25.8% | 24.9× YoY+110.8% | 11.8× YoY-25.5% | 15.9× YoY-31.8% | 23.3× YoY+7.6% | |
| P/B | 1.5× YoY-11.7% | 1.7× YoY+0.6% | 1.7× YoY-19.8% | 2.1× YoY-29.9% | 3.0× YoY+23.5% | |
| P/FCF | 8.9× YoY-32.6% | 13.2× YoY+14.0% | 11.6× YoY-21.2% | 14.7× YoY-39.7% | 24.5× YoY+14.0% | |
| Earnings yield | 0.6% YoY-62.8% | 1.7% YoY-23.1% | 2.2% YoY-42.3% | 3.9% YoY+48.7% | 2.6% YoY+2.3% | |
| FCF yield | 11.2% YoY+48.4% | 7.6% YoY-12.2% | 8.6% YoY+26.9% | 6.8% YoY+65.9% | 4.1% YoY-12.3% | |
| Dividend yield | 7.6% YoY+28.2% | 5.9% YoY-2.3% | 6.1% YoY+26.6% | 4.8% YoY+44.0% | 3.3% YoY-32.1% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: DOC's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all DOC filings on SEC EDGAR → Not investment advice.
